Popular measure in California ballot targets drug pricesBMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5830 (Published 28 October 2016) Cite this as: BMJ 2016;355:i5830
- Michael McCarthy
Despite a $100m (£82m; €92m) opposition campaign largely funded by drug companies, polls indicate that Californians strongly favor a measure in the state’s upcoming 8 November ballot mandating that the state should negotiate steep discounts on drugs purchased through its health programs.
The measure comes at a time when 63% of the US public said in a recent poll that government action to lower prescription drug prices was a top priority. US consumers face the highest drug prices in the world, spending $858 per capita in 2013—more than twice the $400 average in 19 other industrialized nations.1 …